We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TRP:NYSETC Energy Corporation Analysis

Data as of 2026-07-28 - not real-time

$67.65

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

TC Energy trades just above its short‑term moving average and sits in a neutral technical zone, while the MACD has turned bearish and price is hovering between a well‑defined support band and a modest resistance ceiling. Volatility has been elevated over the past month and beta is effectively flat, suggesting limited directional bias from market movements. Valuation metrics indicate that the stock is priced above sector averages, and although the dividend yield is appealing, the payout ratio exceeds the earnings stream, raising questions about long‑term sustainability. The balance sheet is heavily leveraged, with debt far outpacing equity, which could constrain future flexibility.
Revenue is growing at a steady pace and margins remain robust, reflecting the regulated nature of the pipeline network and the stable cash‑flow profile of the business. Analysts have a consensus buy stance, yet their price targets sit below the current market level, hinting at limited upside. The broader market sentiment is marked by extreme optimism, which may be inflating the share price beyond intrinsic fundamentals. Given the mix of solid operational cash generation and pronounced financial leverage, the outlook is best viewed as cautiously neutral, with a tilt toward defensive positioning.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • bearish MACD signal
  • price near resistance with limited upside
  • high valuation relative to peers

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • steady revenue growth and strong margins
  • regulated cash‑flow base
  • elevated debt level limiting upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • stable pipeline infrastructure earnings
  • potential for dividend policy adjustment
  • ongoing regulatory and financing headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth6.60%
Profit Margin22.23%
P/E Ratio28.1
ROE11.33%
ROA3.59%
Debt/Equity166.50
P/B Ratio4.0
Op. Cash Flow$8.6B
Free Cash Flow$267.3M
Industry P/E21.4

Technical Analysis

TrendNeutral
RSI45.7
Support$65.00
Resistance$70.90
MA 20$68.25
MA 50$68.56
MA 200$60.76
MACDBearish
VolumeStable
Fear & Greed Index88.86

Valuation

Target Price$63.36
Upside/Downside-6.34%
GradeOvervalued
TypeBlend
Dividend Yield3.62%

Risk Assessment

Beta-0.02
Volatility21.15%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.